8-Methoxypsoralen, is used in Photochemotherapy (methoxsalen with long wave ultraviolet radiation) is indicated for the repigmentation of idiopathic vitiligo. It is also used in Photopheresis (methoxsalen with long wave ultraviolet radiation of white blood cells) is indicated for use with the UVAR* System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma.
NJ Lowe.; D Weingarten.; T Bourget, LS Moy. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. Journal of the American Academy of Dermatology. 198614 (5), 754-760.
S Igali.; BA Bridges.; MJ Ashwood-Smith. Mutagenesis in Escherichia coli IV. Photosensitization to near ultraviolet light by 8-methoxypsoralen. Journal of the American Academy of Dermatology. 19709 (1), 21-30.
Dichiarazioni di rischio (UE): H302-H317-H350
Harmful if swallowed. May cause an allergic skin reaction. May cause cancer.
Dichiarazioni precauzionali: P201-P261-P280-P301+P312a-P405-P501a
Obtain special instructions before use. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.